TY - JOUR
T1 - Comprehensive In Vivo Interrogation Reveals Phenotypic Impact of Human Enhancer Variants
AU - Kvon, Evgeny Z.
AU - Zhu, Yiwen
AU - Kelman, Guy
AU - Novak, Catherine S.
AU - Plajzer-Frick, Ingrid
AU - Kato, Momoe
AU - Garvin, Tyler H.
AU - Pham, Quan
AU - Harrington, Anne N.
AU - Hunter, Riana D.
AU - Godoy, Janeth
AU - Meky, Eman M.
AU - Akiyama, Jennifer A.
AU - Afzal, Veena
AU - Tran, Stella
AU - Escande, Fabienne
AU - Gilbert-Dussardier, Brigitte
AU - Jean-Marçais, Nolwenn
AU - Hudaiberdiev, Sanjarbek
AU - Ovcharenko, Ivan
AU - Dobbs, Matthew B.
AU - Gurnett, Christina A.
AU - Manouvrier-Hanu, Sylvie
AU - Petit, Florence
AU - Visel, Axel
AU - Dickel, Diane E.
AU - Pennacchio, Len A.
N1 - Funding Information:
The authors would like to acknowledge Muriel Holder-Espinasse (Guy’s Hospital, London), Ghislaine Plessis (CHU Caen), Alain Verloes (CHU Paris), Carine Abel (Hôpital de la Croix Rousse, Lyon), the French reference centers for developmental anomalies, and ERN-ITHACA for patient recruitment. The authors also thank Valentina Snetkova and Marco Osterwalder for help with enhancer pattern annotation and J. Omar Yanez-Cuna for help with designing mutant enhancer alleles. The authors would also like to thank Jonna Austin for photo permissions. This work was supported by National Institutes of Health grants R01HG003988 (to L.A.P.), K99HG009682 (to E.Z.K.), and R01AR067715 (to C.A.G and M.B.D). E.Z.K. was supported by a postdoctoral fellowship from the Helen Hay Whitney Foundation funded by the Howard Hughes Medical Institute . The research was conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231 , University of California. I.O. and S.H. were supported by the Intramural Research Program of the National Library of Medicine at the NIH .
Funding Information:
The authors would like to acknowledge Muriel Holder-Espinasse (Guy's Hospital, London), Ghislaine Plessis (CHU Caen), Alain Verloes (CHU Paris), Carine Abel (H?pital de la Croix Rousse, Lyon), the French reference centers for developmental anomalies, and ERN-ITHACA for patient recruitment. The authors also thank Valentina Snetkova and Marco Osterwalder for help with enhancer pattern annotation and J. Omar Yanez-Cuna for help with designing mutant enhancer alleles. The authors would also like to thank Jonna Austin for photo permissions. This work was supported by National Institutes of Health grants R01HG003988 (to L.A.P.), K99HG009682 (to E.Z.K.), and R01AR067715 (to C.A.G and M.B.D). E.Z.K. was supported by a postdoctoral fellowship from the Helen Hay Whitney Foundation funded by the Howard Hughes Medical Institute. The research was conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231, University of California. I.O. and S.H. were supported by the Intramural Research Program of the National Library of Medicine at the NIH. E.Z.K. D.E.D. A.V. and L.A.P. conceived the project. F.E. B.G.-D. N.J.-M. M.B.D. C.A.G. S.M.-H. and F.P. collected and analyzed clinical data. E.Z.K. curated and analyzed published clinical data. E.Z.K. Y.Z. I.P.-F. C.S.N. T.H.G. M.K. Q.P. A.N.H. R.D.H. J.G. E.M.M. J.A.A. V.A. and S.T. carried out transgenic experiments. E.Z.K. performed the enhancer knockin studies and analyzed the data. E.Z.K. and G.K. performed imaging analysis. S.H. and I.O. performed motif analysis. E.Z.K, D.E.D. A.V. and L.A.P. wrote the manuscript with input from the remaining authors. The authors declare no competing interests.
Publisher Copyright:
© 2020
PY - 2020/3/19
Y1 - 2020/3/19
N2 - Establishing causal links between non-coding variants and human phenotypes is an increasing challenge. Here, we introduce a high-throughput mouse reporter assay for assessing the pathogenic potential of human enhancer variants in vivo and examine nearly a thousand variants in an enhancer repeatedly linked to polydactyly. We show that 71% of all rare non-coding variants previously proposed as causal lead to reporter gene expression in a pattern consistent with their pathogenic role. Variants observed to alter enhancer activity were further confirmed to cause polydactyly in knockin mice. We also used combinatorial and single-nucleotide mutagenesis to evaluate the in vivo impact of mutations affecting all positions of the enhancer and identified additional functional substitutions, including potentially pathogenic variants hitherto not observed in humans. Our results uncover the functional consequences of hundreds of mutations in a phenotype-associated enhancer and establish a widely applicable strategy for systematic in vivo evaluation of human enhancer variants. Development of a scalable in vivo mouse enhancer-reporter assay and its use to systematically interrogate the canonical human ZRS enhancer, which drives Sonic hedgehog expression in mammalian limb development, broadly illuminates enhancer variant pathogenicity.
AB - Establishing causal links between non-coding variants and human phenotypes is an increasing challenge. Here, we introduce a high-throughput mouse reporter assay for assessing the pathogenic potential of human enhancer variants in vivo and examine nearly a thousand variants in an enhancer repeatedly linked to polydactyly. We show that 71% of all rare non-coding variants previously proposed as causal lead to reporter gene expression in a pattern consistent with their pathogenic role. Variants observed to alter enhancer activity were further confirmed to cause polydactyly in knockin mice. We also used combinatorial and single-nucleotide mutagenesis to evaluate the in vivo impact of mutations affecting all positions of the enhancer and identified additional functional substitutions, including potentially pathogenic variants hitherto not observed in humans. Our results uncover the functional consequences of hundreds of mutations in a phenotype-associated enhancer and establish a widely applicable strategy for systematic in vivo evaluation of human enhancer variants. Development of a scalable in vivo mouse enhancer-reporter assay and its use to systematically interrogate the canonical human ZRS enhancer, which drives Sonic hedgehog expression in mammalian limb development, broadly illuminates enhancer variant pathogenicity.
KW - CRISPR/Cas9
KW - Sonic hedgehog
KW - ZRS
KW - cis-regulatory element
KW - enhancer
KW - genome editing
KW - limb development
KW - mutation
KW - polydactyly
KW - rare non-coding variant
UR - http://www.scopus.com/inward/record.url?scp=85081910454&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2020.02.031
DO - 10.1016/j.cell.2020.02.031
M3 - Article
C2 - 32169219
AN - SCOPUS:85081910454
VL - 180
SP - 1262-1271.e15
JO - Cell
JF - Cell
SN - 0092-8674
IS - 6
ER -